Approval of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.7 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide Limited (formerly NPL Chemicals Limited) reported its Q2 and H1 FY26 unaudited results. Revenue from operations for the half-year fell about 10.6% year-on-year to ₹13,494 lakhs (vs ₹15,101 lakhs in H1 FY25). The company swung to a loss of ₹251.54 lakhs for H1 FY26, compared with a profit of ₹589.87 lakhs in the same period last year. In Q2 alone, the company posted a loss of ₹35.95 lakhs against a profit of ₹9.68 lakhs a year earlier, with basic EPS turning negative at ₹(0.67) for the quarter. The statutory auditor (Kalyaniwalla & Mistry LLP) issued an unmodified limited review conclusion with no qualifications. The business remains a single segment — manufacturing of Hydrogen Peroxide. Operating cash flow stayed positive at ₹937 lakhs for the half-year, and the balance sheet remains virtually debt-free with equity of ₹34,926 lakhs.
The sharp swing to a half-year loss and the ~11% revenue decline are negatives that may pressure the stock in the short term. However, the clean audit report, strong equity base, low borrowings, and continued positive operating cash flow provide some cushion for shareholders.